Join to access to all OVN content. Join for Free

Results for 'Medical Watch'

How Medical Affairs Professionals Should Engage with Digital Opinion Leaders
Partner Avatar MSL Talk: Tom Caravela, Paul Ward
How Medical Affairs Professionals Should Engage with Digital Opinion Leaders

Digital Opinion Leaders, Medical Affairs, MSL Talk, Paul Ward, Tom Caravela, Medical Watch, AI in Medical Affairs, Digital Engagement, Online Misinformation, Scientific Credibility

In this episode of MSL Talk, Tom Caravela sits down with Paul Ward for an insightful conversation on the evolving role of Digital Opinion Leaders (DOLs) in Medical Affairs. Sponsored by Medical Watch, this episode explores why DOLs matter, how to identify the right ones, and what tools MSLs can use …

May 20th • 37 mins listen

Patients as a key stakeholder for scientific conferences
Partner Avatar Dawn Lobban, Medical and Patient Engagement Consultant, Simon Stones, Senior Medical Writer, Envision Pharma Group
Patients as a key stakeholder for scientific conferences

patient involvement in scientific congresses, patient advocate in research, ISMPP podcasts, medical and patient engagement, juvenile arthritis awareness, patient voice in healthcare

In this episode of Informed, guest host Dawn Lobban is joined by Simon Stones, an experienced patient advocate and senior medical writer. They discuss the topic of patients at scientific congresses and conferences. Simon shares his journey of being diagnosed with juvenile arthritis and inflammator…

Nov 23rd • 17 mins listen

Aspiring MSL Insights: The Do's and Don'ts for MSL Presentations
Partner Avatar Michael Pietrack
Aspiring MSL Insights: The Do's and Don'ts for MSL Presentations

Aspiring MSL Insights: The Do's and Don'ts for MSL Presentations In this video, Michael Pietrack shares three best practices to implement and the three pitfalls to avoid ❌ in your MSL Presentation. If you’ve been following our Aspiring MSL content, please subscribe to the channel…

Aug 21st • 3 mins listen

Related Topics

Loading...